Association between MIS-C and Functional Gastrointestinal Disorders in Children: A Cross-Sectional Study

 

 Buy Article Permissions and Reprints

Abstract

Objective Multisystem inflammatory syndrome in children (MIS-C) is a serious complication of coronavirus disease 2019 which causes a hyperinflammatory syndrome that can affect all organ systems. Functional gastrointestinal disorders (FGIDs) are a heterogeneous disease spectrum with unclear etiology. Today, it is known that low-grade inflammation can cause FGIDs. Our aim in this study was to investigate whether there is a higher frequency of FGID in children diagnosed with MIS-C.

Methods In this study, 48 pediatric patients diagnosed with MIS-C were evaluated for functional gastrointestinal diseases according to the Rome IV criteria at least 6 months after diagnosis. The control group consisted of 61 pediatric patients without any chronic disease.

Results In our study, the overall prevalence of FGIDs was 54.1% (n = 26) in the patient group and 22.9% (n = 14) in the control group. The difference between the groups was statistically significant (p < 0.001). The frequencies of undiagnosed abdominal pain, irritable bowel syndrome, constipation, and dyspepsia were 41.6% (n = 20), 12.5% (n = 6), 8.3% (n = 4), and 6.2% (n = 3) in the patient group, respectively. In the control group, the corresponding rates were 9.8% (n = 6), 3.2% (n = 2), 4.9% (n = 3), and 4.9% (n = 3), respectively. A significant difference was observed between the patient and control groups in terms of functional abdominal pain (p < 0.001).

Conclusion The overall frequency of FGIDs and the prevalence of functional abdominal pain were higher in MIS-C patients than in control subjects. The data from this study support the hypothesis that FGIDs are more common in patients diagnosed with MIS-C than in healthy controls.

Ethics Approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Adıyaman University Faculty of Medicine Non-Interventional Clinical Research Ethics Committee.

Consent to Participate

Informed consent was obtained from legal guardians to participate.

Consent for Publication

Informed consent was obtained from legal guardians for publication.

Publication History

Received: 30 March 2023

Accepted: 17 August 2023

Article published online:
22 September 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Castagnoli R, Votto M, Licari A. et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr 2020; 174 (09) 882-889
  CrossrefPubMedGoogle Scholar
• 2 Royal College of Paediatrics and Child Health. Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19. Accessed April 3, 2022 at: https://www.rcpch.ac.uk/work-we-do/bpsu/study-multisystem-inflammatory-syndrome-kawasaki-disease-toxic-shock-syndrome
  PubMedGoogle Scholar
• 3 Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). Accessed April 3, 2022 at: https://www.cdc.gov/mis/mis-c.html
  PubMedGoogle Scholar
• 4 World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19. Accessed April 3, 2022 at: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19
  PubMedGoogle Scholar
• 5 Esposito S, Principi N. Multisystem inflammatory syndrome in children related to SARS-CoV-2. Paediatr Drugs 2021; 23 (02) 119-129
  PubMedGoogle Scholar
• 6 Dufort EM, Koumans EH, Chow EJ. et al; New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem inflammatory syndrome in children in New York state. N Engl J Med 2020; 383 (04) 347-358
  CrossrefPubMedGoogle Scholar
• 7 Feldstein LR, Rose EB, Horwitz SM. et al; Overcoming COVID-19 Investigators, CDC COVID-19 Response Team. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020; 383 (04) 334-346
  CrossrefPubMedGoogle Scholar
• 8 Yilmaz Ciftdogan D, Ekemen Keles Y, Cetin BS. et al. COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group. Eur J Pediatr 2022; 181 (05) 2031-2043
  CrossrefPubMedGoogle Scholar
• 9 Sahn B, Eze OP, Edelman MC. et al. Features of intestinal disease associated with COVID-related multisystem inflammatory syndrome in children. J Pediatr Gastroenterol Nutr 2021; 72 (03) 384-387
  CrossrefPubMedGoogle Scholar
• 10 Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil 2008; 20 (Suppl. 01) 121-129
  CrossrefPubMedGoogle Scholar
• 11 Boronat AC, Ferreira-Maia AP, Matijasevich A, Wang YP. Epidemiology of functional gastrointestinal disorders in children and adolescents: a systematic review. World J Gastroenterol 2017; 23 (21) 3915-3927
  CrossrefPubMedGoogle Scholar
• 12 Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002; 97 (09) 2290-2299
  CrossrefPubMedGoogle Scholar
• 13 Keely S, Walker MM, Marks E, Talley NJ. Immune dysregulation in the functional gastrointestinal disorders. Eur J Clin Invest 2015; 45 (12) 1350-1359
  CrossrefPubMedGoogle Scholar
• 14 Kassinen A, Krogius-Kurikka L, Mäkivuokko H. et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133 (01) 24-33
  CrossrefPubMedGoogle Scholar
• 15 Annaházi A, Ferrier L, Bézirard V. et al. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS. Am J Gastroenterol 2013; 108 (08) 1322-1331
  CrossrefPubMedGoogle Scholar
• 16 Matricon J, Meleine M, Gelot A. et al. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 2012; 36 (11–12): 1009-1031
  CrossrefPubMedGoogle Scholar
• 17 Vanheel H, Vicario M, Vanuytsel T. et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014; 63 (02) 262-271
  CrossrefPubMedGoogle Scholar
• 18 Martínez C, Lobo B, Pigrau M. et al. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut 2013; 62 (08) 1160-1168
  CrossrefPubMedGoogle Scholar
• 19 Deshmukh V, Motwani R, Kumar A, Kumari C, Raza K. Histopathological observations in COVID-19: a systematic review. J Clin Pathol 2021; 74 (02) 76-83
  CrossrefPubMedGoogle Scholar
• 20 Britton GJ, Chen-Liaw A, Cossarini F. et al. Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. Sci Rep 2021; 11 (01) 13308
  CrossrefPubMedGoogle Scholar
• 21 Whittaker E, Bamford A, Kenny J. et al; PIMS-TS Study Group and EUCLIDS and PERFORM Consortia. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324 (03) 259-269
  CrossrefPubMedGoogle Scholar
• 22 Gruber CN, Patel RS, Trachtman R. et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell 2020; 183 (04) 982-995.e14
  CrossrefPubMedGoogle Scholar
• 23 Consiglio CR, Cotugno N, Sardh F. et al; CACTUS Study Team. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell 2020; 183 (04) 968-981.e7
  CrossrefPubMedGoogle Scholar
• 24 Kindt S, Van Oudenhove L, Broekaert D. et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 2009; 21 (04) 389-398
  CrossrefPubMedGoogle Scholar
• 25 Rajindrajith S, Zeevenhooven J, Devanarayana NM, Perera BJC, Benninga MA. Functional abdominal pain disorders in children. Expert Rev Gastroenterol Hepatol 2018; 12 (04) 369-390
  CrossrefPubMedGoogle Scholar
• 26 Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional disorders: children and adolescents. Gastroenterology 2016; 16: 181-185
  PubMedGoogle Scholar
• 27 Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol 2010; 1 (03) 97-105
  CrossrefPubMedGoogle Scholar
• 28 Lewis ML, Palsson OS, Whitehead WE, van Tilburg MAL. Prevalence of functional gastrointestinal disorders in children and adolescents. J Pediatr 2016; 177: 39-43.e3
  CrossrefPubMedGoogle Scholar
• 29 Korterink JJ, Diederen K, Benninga MA, Tabbers MM. Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. PLoS One 2015; 10 (05) e0126982
  CrossrefPubMedGoogle Scholar
• 30 Youssef NN, Murphy TG, Langseder AL, Rosh JR. Quality of life for children with functional abdominal pain: a comparison study of patients' and parents' perceptions. Pediatrics 2006; 117 (01) 54-59
  CrossrefPubMedGoogle Scholar
• 31 Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20 (Suppl. 07) 31-39
  CrossrefPubMedGoogle Scholar
• 32 Yasuhara J, Watanabe K, Takagi H, Sumitomo N, Kuno T. COVID-19 and multisystem inflammatory syndrome in children: a systematic review and meta-analysis. Pediatr Pulmonol 2021; 56 (05) 837-848
  CrossrefPubMedGoogle Scholar
• 33 Bautista-Rodriguez C, Sanchez-de-Toledo J, Clark BC. et al. Multisystem inflammatory syndrome in children: an international survey. Pediatrics 2021; 147 (02) e2020024554
  CrossrefPubMedGoogle Scholar
• 34 Walker MM, Talley NJ, Prabhakar M. et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2009; 29 (07) 765-773
  CrossrefPubMedGoogle Scholar
• 35 Barbara G, Grover M, Bercik P. et al. Rome Foundation Working Team report on post-infection irritable bowel syndrome. Gastroenterology 2019; 156 (01) 46-58.e7
  CrossrefPubMedGoogle Scholar
• 36 Schmulson M, Ghoshal UC, Barbara G. Managing the inevitable surge of post-COVID-19 functional gastrointestinal disorders. Am J Gastroenterol 2021; 116 (01) 4-7
  CrossrefPubMedGoogle Scholar
• 37 Börekci E, Celikbilek M, Soytürk M, Akar S, Börekci H, Günaydin I. Functional gastrointestinal disorders in patients with familial Mediterranean fever. Int J Rheum Dis 2017; 20 (12) 2101-2105
  CrossrefPubMedGoogle Scholar
• 38 Miller J, Cantor A, Zachariah P, Ahn D, Martinez M, Margolis KG. Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children that is related to coronavirus disease 2019: a single center experience of 44 cases. Gastroenterology 2020; 159 (04) 1571-1574.e2
  CrossrefPubMedGoogle Scholar
• 39 Cabrero-Hernández M, García-Salido A, Leoz-Gordillo I. et al. Severe SARS-CoV-2 infection in children with suspected acute abdomen: a case series from a tertiary hospital in Spain. Pediatr Infect Dis J 2020; 39 (08) e195-e198
  CrossrefPubMedGoogle Scholar
• 40 Diorio C, Henrickson SE, Vella LA. et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest 2020; 130 (11) 5967-5975
  CrossrefPubMedGoogle Scholar